Psychiatry & Neurology Doctors in Peterborough, NH Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Dr. Michele Gunning, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 458 Old Street Rd, Suite 202, Peterborough, NH 03458 Phone: 603-942-4690

Rand S Swenson, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 454 Old Street Rd, Peterborough, NH 03458 Phone: 603-924-7191    Fax: 603-924-3569

Dr. Paul Millard Hardy, MD Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Phoenix Mill Ln, Suite 101, Peterborough, NH 03458 Phone: 603-784-5266    Fax: 603-784-5295

Dr. Teresa Mary Cadorette, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 45 Main St, Suite 101, Peterborough, NH 03458 Phone: 603-924-0804    Fax: 603-924-0844

Peter Olsson, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 454 Old Street Rd, Suite 305, Peterborough, NH 03458 Phone: 603-924-4690    Fax: 603-924-3569

Jeffrey M Haines, MD Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 174 Concord St, Suite 160, Peterborough, NH 03458 Phone: 603-924-6774    Fax: 603-924-6778

News Archive

InvoTek introduces new Safe Laser System for persons with limited movement

InvoTek, Inc., a research and development company in Alma, Arkansas, has launched a new product using safe laser technology that enables a person with limited movement to write, communicate, and control their environment. The product will be unveiled at the Abilities Expo 2011 in Newark, New Jersey on Friday, May 20, 2011.

Researchers study new drug and indications for heated chemotherapy treatment

Studies have shown that surgery combined with Intraperitoneal Hyperthermic Chemotherapy (IPHC) can improve survival rates for select patients with peritoneal carcinoma (cancer of the lining of the abdominal cavity) that has spread from colorectal or appendix cancer.

Pharmos announces results of its Phase 2b Dextofisopam trial

Pharmos Corporation (Pink Sheets: PARS); on September 14, 2009, Pharmos announced the results of its Phase 2b Dextofisopam trial for the treatment of diarrhea predominant and alternating diarrhea and constipation irritable bowel syndrome.

Pregnant mothers who are vitamin D deficient raise risk of language difficulties in kids: Study

The Telethon Institute for Child Health Research study is the first to show low levels of the vitamin in utero can harm a child's language development, including the ability to pick up new words and string together sentences.

Some drug companies experiencing higher prescription volume, revenue with Medicare drug benefit

The Philadelphia Inquirer on Monday examined how the Medicare prescription drug benefit "is boosting prescription volume and revenue for drug companies."

Read more Medical News

› Verified 6 days ago